[1]王文岳 谢利民 宋康康 于潼 沈凌 卫成军△.益气通脉方与低分子肝素预防髋部大手术下肢深静脉血栓的随机对照研究[J].中国中医骨伤科杂志,2016,24(11):15-18，23.
　WANG Wenyue XIE Limin SONG Kangkang YU Tong SHEN Ling WEI Chengjun.Randomized Control Study on Yiqitongmai Decoction and Low Molecular Weight Heparin for Preventing Deep Vein Thrombosis in the Patients Received Major Hip Surgery[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2016,24(11):15-18，23.
点击复制

益气通脉方与低分子肝素预防髋部大手术下肢深静脉血栓的随机对照研究
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第24卷
期数:
2016年11期
页码:
15-18，23
栏目:
临床研究
出版日期:
2016-11-01

文章信息/Info

Title:
Randomized Control Study on Yiqitongmai Decoction and Low Molecular Weight Heparin for Preventing Deep Vein Thrombosis in the Patients Received Major Hip Surgery
文章编号:
1005-0205(2016)11-0015-04
作者:
王文岳1 谢利民1 宋康康1 于潼1 沈凌1 卫成军1△
1.中国中医科学院广安门医院骨科(北京,100053)
△.通信作者 E-mail:gamgkwei@163.com
Author(s):
WANG Wenyue1 XIE Limin1 SONG Kangkang1 YU Tong1 SHEN Ling1 WEI Chengjun1△
1.Department of Orthopaedics,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China.
关键词:
髋部大手术;  深静脉血栓;  益气通脉方;  低分子肝素
Keywords:
major hip surgery;  deep vein thrombosis;  Yiqitongmai decoction;  low molecular weight heparin
分类号:
R543.6
文献标志码:
A
摘要:
目的:观察益气通脉方与低分子肝素预防髋部大手术下肢深静脉血栓的临床疗效并评价其安全性。方法:收集2011年10月至2015年6月髋部大手术患者共46例,随机分为试验组和对照组,各23例。试验组给予口服益气通脉汤,对照组给予皮下注射低分子肝素钙,治疗、观察周期2周,对比两组术后2周下肢深静脉血栓发生率及不良反应发生率。结果:试验组小腿肌间静脉血栓2例,股前静脉血栓1例,股深静脉血栓1例,DVT发生率19.04%; 对照组小腿肌间静脉血栓2例,股深静脉血栓1例,DVT发生率 14.28%; 两组在DVT发生率和术后并发症方面,差异无统计学意义(P>0.05)。试验组术后出血量小于对照组(P<0.05)。结论:益气通脉方具有预防老年患者髋部大手术深静脉血栓形成的作用,与低分子肝素相比,益气通脉方减少了术后出血,为益气活血利水法有效预防DVT提供了临床依据,两者安全性相当。
Abstract:
Objective:To observe the therapeutic effect and assess the safety of Yiqitongmai decoction and low molecular weight heparin for preventing deep vein thrombosis(DVT)in senile patients received major hip surgery.Methods:Forty six patients received major hip surgery were enrolled from October 2011 to June 2015.They were randomly divided into experimental group and control group(23 cases in each group).The experimental group was given oral Yiqitongmai decoction.The control group was given low molecular weight heparin(LMWH)hypodermic injection.The therapeutic and observation period was 2 weeks.The clinical symptoms,physical signs,bleeding tendency,and the changes of color Doppler Ultrasound were documented.Results:There were two cases with calf muscular venous thrombosis,one case with anterior femoral venous thrombosis,and one case with deep femoral venous thrombosis in the experimental group.And there were 2 cases with calf muscular venous thrombosis and one case with deep femoral venous thrombosis in the control group.The incidence of DVT was 19.04% and 14.28% respectively.The DVT rate and the complication was not significantly different between two groups(P>0.05).The postoperative blood volume in the experimental group was less than the control group(P<0.05).Conclusion:The Yiqitongmai decoction is effective for preventing DVT in senile patients received major hip surgery.Compared with LMWH,Yiqitongmai decoction can decrease the bleeding,with the same safety.

参考文献/References:

[1] Lieberman JR,Geerts WH.Prevention of venous thrombo-embolism after total hip and knee arthroplasty[J].J Bone Joint Surg Am,1994,76(8):1239-1250.
[2] Piovella F,Wang CJ,Lu H,et al.Deep-vein thrombosis rates after major orthopedic surgery in Asia[J].An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.J Thromb Haemost,2005,3(12):2664-2670.
[3] 邱贵兴,杨庆铭,余楠生,等.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822.
[4] 余楠生,陈东峰,卢伟杰,等.低分子肝素联合间歇充气加压预防人工关节置换术后下肢深静脉血栓形成[J].中华骨科杂志,2006,26(12):823-826.
[5] Geerts WH,Bergqvist D,Pineo GF,et al.Prevention of venous thromboembolism:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition)[J].Chest,2008,133(6 Suppl):381-453.
[6] Falck-Ytter Y,Francis CW,Johanson NA,et al.Prevention of VTE in orthopedic surgery patients:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,141(2 Suppl):278-325.
[7] Meza RG,Esquivel GR,Martinez DCSA,et al.Prophylaxis of venous thromboembolic disease in high-risk orthopedic surgery[J].Gac Med Mex,2012,148(2):144-152.
[8] Dahl OE,Quinlan DJ,Bergqvist D,et al.A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty[J].J Thromb Haemost,2010,8(9):1966-1975.
[9] Migita K,Bito S,Nakamura M,et al.Venous thromboembolism after total joint arthroplasty:results from a Japanese multicenter cohort study[J].Arthritis Res Ther,2014,16(4):R154.
[10] Forster R,Stewart M.Anticoagulants(extended duration)for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair[J].Cochrane Database Syst Rev,2016,30(3):CD004179.
[11] 王婕,郭利平,王怡.中药对血小板功能影响的研究进展[J].北京中医药,2008,27(11):893-896.
[12] 王文岳 谢利民,从“瘀水论”谈防治髋部术后深静脉血栓形成[J].中国中医骨伤科杂志,2012,20(8):79-80.
[13] 杨佐明,刘晓明,戴士峰,等.低分子肝素预防人工全髋关节置换术后深静脉血栓疗效观察[J].中国修复重建外科杂志,2010,24(9),1058-1061.
[14] 任青松.中西医结合治疗下肢深静脉血栓形成126例[J].光明中医,2012,27(5):986-987.

更新日期/Last Update: 2016-11-15